AVIVA PLC - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AVIVA PLC ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q3 2022$422,000
-26.6%
47,600
+4.6%
0.00%
-33.3%
Q2 2022$575,000
-26.1%
45,500
+10.7%
0.00%
-25.0%
Q1 2022$778,000
-45.4%
41,100
+1.2%
0.00%
-33.3%
Q4 2021$1,424,000
+25.2%
40,600
+29.7%
0.01%
+20.0%
Q3 2021$1,137,000
+26.5%
31,300
+36.7%
0.01%
+25.0%
Q2 2021$899,000
+38.9%
22,9000.0%0.00%
+33.3%
Q1 2021$647,000
-15.1%
22,900
-3.8%
0.00%
-25.0%
Q4 2020$762,000
+2.1%
23,800
+3.0%
0.00%0.0%
Q3 2020$746,000
+12.2%
23,100
-4.1%
0.00%0.0%
Q2 2020$665,000
+79.2%
24,100
+15.9%
0.00%
+33.3%
Q1 2020$371,000
-31.5%
20,800
-3.7%
0.00%0.0%
Q4 2019$542,000
+71.5%
21,600
+22.0%
0.00%
+50.0%
Q3 2019$316,000
-12.0%
17,700
+8.6%
0.00%0.0%
Q2 2019$359,000
-24.7%
16,300
+4.5%
0.00%
-33.3%
Q1 2019$477,000
+71.0%
15,600
+28.9%
0.00%
+50.0%
Q4 2018$279,00012,1000.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders